$20.270
+1.119 (+5.52%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
该买入 Braveheart Bio, Inc. 股票吗？
Braveheart Bio, Inc. is not a good buy right now due to significant financial losses and negative price momentum. The current price is $18.71, with a recent 5-day change of -6.54% and a year-to-date change of only +3.94%. The company's net loss for Q2 2026 was $18.60 million, up from $0.38 million the previous year, indicating worsening financial health. Additionally, the RSI is at 32.844, suggesting the stock is oversold, but this may not be enough to justify a buy given the ongoing losses and high clinical development costs.
BRVE 股价于 Tuesday 收于 $20.27，此前上涨 +5.52%
Braveheart Bio, Inc. (BRVE) last closed at $20.27, gaining +5.52%. These facts feed the 1-day and 1-week BRVE price prediction above.
预测驱动因素
Braveheart Bio, Inc.（BRVE）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
BRVE 季节性分析
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。